Germany vs Paraguay: The number of people with susceptibility test result for rifampicin
Germany
1,440
in 2021
Paraguay
1,639
in 2021
Germany rank
58th
Paraguay rank
56th
The number of people with susceptibility test result for rifampicin over time
- Germany
- Paraguay
How they compare
Paraguay currently reports 1,639 against 1,440 in Germany, a difference of 199.
That makes Paraguay's figure about 1.1 times Germany's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Paraguay ahead.
Germany ranks 58th and Paraguay ranks 56th of 155 countries.
Germany has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Germany | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,298 | 706 | 592 | Germany |
| 2020s | 1,502 | 1,204 | 299 | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Germany or Paraguay?
- Paraguay, at 1,639 against 1,440 in Germany as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Germany and Paraguay?
- 199, with Paraguay ahead.
- How many years of comparable data are there for Germany and Paraguay?
- 5 years are reported by both, from 2017 to 2021.
- How do Germany and Paraguay rank globally for the number of people with susceptibility test result for rifampicin?
- Germany ranks 58th and Paraguay ranks 56th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.